Applied DNA Raises $1.5 Million In Secured Convertible Notes
July 17th, 2019
Tag: Corporate/Financial News
Applied DNA Reports FQ’19 Q2 Results
May 9th, 2019
Applied DNA Reports FY’19 Q1 Results
February 7th, 2019
Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants
December 27th, 2018
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants
December 21st, 2018
Applied DNA Announces Proposed Public Offering of Common Stock and Warrants
December 19th, 2018
APDN Announces Selected Preliminary 2018 Year End, Q4 Financial Results
December 13th, 2018
Applied DNA to Participate at Cannabis Capital Forum on December 7
December 5th, 2018
Applied DNA Enters FY2019 with Strong Business Momentum
October 24th, 2018